{"id":288857,"date":"2026-08-31T12:00:00","date_gmt":"2026-08-31T10:00:00","guid":{"rendered":"https:\/\/geneveinfos.ch\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/"},"modified":"2026-11-09T13:37:08","modified_gmt":"2026-11-09T12:37:08","slug":"addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027","status":"publish","type":"post","link":"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/","title":{"rendered":"Addex Therapeutics: cash runway extended to end-2027"},"content":{"rendered":"<p class=\"gi-temps\">\u23f1 1 min read<\/p>\n<h3>Background<\/h3>\n<p>Founded in 2002 in Geneva, Addex Therapeutics is a clinical-stage biotech. It develops small-molecule allosteric modulators for neurological disorders.<\/p>\n<h3>The key points<\/h3>\n<p>Addex Therapeutics has raised 2.8 million dollars in gross proceeds through its at-the-market programme with US bank H.C. Wainwright. The sale extends its cash runway into the fourth quarter of 2027.<\/p>\n<p>Its lead candidate, dipraglurant, targets recovery after brain injury, including stroke and traumatic brain injury.<\/p>\n<h3>Key figures<\/h3>\n<ul>\n<li>Amount raised: 2.8 million dollars gross.<\/li>\n<li>Programme ceiling, raised in December 2025: 3.3 million dollars.<\/li>\n<li>H.C. Wainwright commission: 3% of gross proceeds.<\/li>\n<li>Shares issued: just over 218.5 million.<\/li>\n<\/ul>\n<h3>What it means for businesses<\/h3>\n<p>Addex has sold 437,869 American depositary shares, representing more than 52 million ordinary shares. Shares in circulation now exceed 210 million.<\/p>\n<h3>What's next<\/h3>\n<p>Beyond its own pipeline, Addex launched the Geneva spin-off Neurosterix and led an investment in Stalicla.<\/p>\n<h3>Read also<\/h3>\n<ul class=\"gi-related\">\n<li><a href=\"https:\/\/geneveinfos.ch\/en\/2026\/10\/23\/release-therapeutics-cns-targeted-technology-earns-2026-disruptive-innovation-award-from-geneva-university-hospitals-ein-presswire\/\">Release Therapeutics: HUG disruptive innovation award<\/a><\/li>\n<li><a href=\"https:\/\/geneveinfos.ch\/en\/2026\/11\/02\/le-groupe-pharmaceutique-catalan-ste-pharmaceuticals-va-simplanter-a-couvet\/\">Couvet: STE Pharmaceuticals plans a site by 2032<\/a><\/li>\n<\/ul>\n<h3>Sources<\/h3>\n<ul class=\"gi-sources\">\n<li><a href=\"https:\/\/ggba.swiss\/en\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/\">GGBA \u2013 Addex Therapeutics extends its cash runway into the fourth quarter of 2027<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Addex Therapeutics has raised 2.8 million dollars in gross proceeds through its at-the-market programme with US bank H.C. Wainwright.<\/p>","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[102],"tags":[127],"class_list":["post-288857","post","type-post","status-publish","format-standard","hentry","category-pharma-biotech","tag-fiche-bilingue"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.5 - aioseo.com -->\n\t<meta name=\"description\" content=\"Addex Therapeutics, biotech genevoise, l\u00e8ve 2,8 millions de dollars et prolonge sa tr\u00e9sorerie jusqu&#039;au quatri\u00e8me trimestre 2027.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"R\u00e9daction Gen\u00e8ve Infos\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.5\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_GB\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Gen\u00e8ve Infos - Le site d&#039;informations de la r\u00e9gion genevoise\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Addex Therapeutics : tr\u00e9sorerie prolong\u00e9e jusqu\u2019\u00e0 fin 2027 - Gen\u00e8ve Infos\" \/>\n\t\t<meta property=\"og:description\" content=\"Addex Therapeutics, biotech genevoise, l\u00e8ve 2,8 millions de dollars et prolonge sa tr\u00e9sorerie jusqu&#039;au quatri\u00e8me trimestre 2027.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-08-31T10:00:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-11-09T12:37:08+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61576016541234\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Addex Therapeutics : tr\u00e9sorerie prolong\u00e9e jusqu\u2019\u00e0 fin 2027 - Gen\u00e8ve Infos\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Addex Therapeutics, biotech genevoise, l\u00e8ve 2,8 millions de dollars et prolonge sa tr\u00e9sorerie jusqu&#039;au quatri\u00e8me trimestre 2027.\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/08\\\/31\\\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/category\\\/pharma-biotech\\\/#listItem\",\"name\":\"Pharma &amp; biotech\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/category\\\/pharma-biotech\\\/#listItem\",\"position\":2,\"name\":\"Pharma &amp; biotech\",\"item\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/category\\\/pharma-biotech\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/08\\\/31\\\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\\\/#listItem\",\"name\":\"Addex Therapeutics : tr\\u00e9sorerie prolong\\u00e9e jusqu&rsquo;\\u00e0 fin 2027\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/08\\\/31\\\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\\\/#listItem\",\"position\":3,\"name\":\"Addex Therapeutics : tr\\u00e9sorerie prolong\\u00e9e jusqu&rsquo;\\u00e0 fin 2027\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/category\\\/pharma-biotech\\\/#listItem\",\"name\":\"Pharma &amp; biotech\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/08\\\/31\\\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\\\/#newsarticle\",\"name\":\"Addex Therapeutics : tr\\u00e9sorerie prolong\\u00e9e jusqu\\u2019\\u00e0 fin 2027 - Gen\\u00e8ve Infos\",\"headline\":\"Addex Therapeutics : tr\\u00e9sorerie prolong\\u00e9e jusqu&rsquo;\\u00e0 fin 2027\",\"author\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/redaction-geneve-infos\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/geneve_infos_logo.png\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#articleImage\"},\"datePublished\":\"2026-08-31T12:00:00+02:00\",\"dateModified\":\"2026-11-09T13:37:08+01:00\",\"inLanguage\":\"en-GB\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/08\\\/31\\\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/08\\\/31\\\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\\\/#webpage\"},\"articleSection\":\"Pharma &amp; biotech, Fiche bilingue\",\"dateline\":\"Published on August 31, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#organization\",\"name\":\"Gen\\u00e8ve Infos\",\"description\":\"Revue de presse et analyses sur l'\\u00e9conomie et l'urbanisme de Gen\\u00e8ve.\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/geneve_infos_logo.png\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/08\\\/31\\\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/08\\\/31\\\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61576016541234\",\"https:\\\/\\\/www.instagram.com\\\/geneveinfos.ch?igsh=MXhkaTV2bXBkZm00NQ==\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/geneveinfos-ch\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/redaction-geneve-infos\\\/#author\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/redaction-geneve-infos\\\/\",\"name\":\"R\\u00e9daction Gen\\u00e8ve Infos\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/08\\\/31\\\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4a611ac9406717aef02499144d0e12a8f5e1327b66a2e6023de2c094c4937e1d?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"R\\u00e9daction Gen\\u00e8ve Infos\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/08\\\/31\\\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\\\/#webpage\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/08\\\/31\\\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\\\/\",\"name\":\"Addex Therapeutics : tr\\u00e9sorerie prolong\\u00e9e jusqu\\u2019\\u00e0 fin 2027 - Gen\\u00e8ve Infos\",\"description\":\"Addex Therapeutics, biotech genevoise, l\\u00e8ve 2,8 millions de dollars et prolonge sa tr\\u00e9sorerie jusqu'au quatri\\u00e8me trimestre 2027.\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/08\\\/31\\\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/redaction-geneve-infos\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/redaction-geneve-infos\\\/#author\"},\"datePublished\":\"2026-08-31T12:00:00+02:00\",\"dateModified\":\"2026-11-09T13:37:08+01:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/\",\"name\":\"Gen\\u00e8ve Infos\",\"description\":\"Le site d'informations de la r\\u00e9gion genevoise\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Addex Therapeutics: cash runway extended to end-2027 - Gen\u00e8ve Infos","description":"Addex Therapeutics, a Geneva biotech, raises 2.8 million dollars and extends its cash runway into the fourth quarter of 2027.","canonical_url":"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/geneveinfos.ch\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/#listItem","name":"Pharma &amp; biotech"}},{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/#listItem","position":2,"name":"Pharma &amp; biotech","item":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/","nextItem":{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/#listItem","name":"Addex Therapeutics : tr\u00e9sorerie prolong\u00e9e jusqu&rsquo;\u00e0 fin 2027"},"previousItem":{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/#listItem","position":3,"name":"Addex Therapeutics : tr\u00e9sorerie prolong\u00e9e jusqu&rsquo;\u00e0 fin 2027","previousItem":{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/#listItem","name":"Pharma &amp; biotech"}}]},{"@type":"NewsArticle","@id":"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/#newsarticle","name":"Addex Therapeutics : tr\u00e9sorerie prolong\u00e9e jusqu\u2019\u00e0 fin 2027 - Gen\u00e8ve Infos","headline":"Addex Therapeutics : tr\u00e9sorerie prolong\u00e9e jusqu&rsquo;\u00e0 fin 2027","author":{"@id":"https:\/\/geneveinfos.ch\/en\/author\/redaction-geneve-infos\/#author"},"publisher":{"@id":"https:\/\/geneveinfos.ch\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2025\/04\/geneve_infos_logo.png","@id":"https:\/\/geneveinfos.ch\/en\/#articleImage"},"datePublished":"2026-08-31T12:00:00+02:00","dateModified":"2026-11-09T13:37:08+01:00","inLanguage":"en-GB","mainEntityOfPage":{"@id":"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/#webpage"},"isPartOf":{"@id":"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/#webpage"},"articleSection":"Pharma &amp; biotech, Fiche bilingue","dateline":"Published on August 31, 2026."},{"@type":"Organization","@id":"https:\/\/geneveinfos.ch\/en\/#organization","name":"Gen\u00e8ve Infos","description":"Revue de presse et analyses sur l'\u00e9conomie et l'urbanisme de Gen\u00e8ve.","url":"https:\/\/geneveinfos.ch\/en\/","logo":{"@type":"ImageObject","url":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2025\/04\/geneve_infos_logo.png","@id":"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/#organizationLogo"},"image":{"@id":"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61576016541234","https:\/\/www.instagram.com\/geneveinfos.ch?igsh=MXhkaTV2bXBkZm00NQ==","https:\/\/www.linkedin.com\/company\/geneveinfos-ch"]},{"@type":"Person","@id":"https:\/\/geneveinfos.ch\/en\/author\/redaction-geneve-infos\/#author","url":"https:\/\/geneveinfos.ch\/en\/author\/redaction-geneve-infos\/","name":"R\u00e9daction Gen\u00e8ve Infos","image":{"@type":"ImageObject","@id":"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/4a611ac9406717aef02499144d0e12a8f5e1327b66a2e6023de2c094c4937e1d?s=96&d=mm&r=g","width":96,"height":96,"caption":"R\u00e9daction Gen\u00e8ve Infos"}},{"@type":"WebPage","@id":"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/#webpage","url":"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/","name":"Addex Therapeutics : tr\u00e9sorerie prolong\u00e9e jusqu\u2019\u00e0 fin 2027 - Gen\u00e8ve Infos","description":"Addex Therapeutics, biotech genevoise, l\u00e8ve 2,8 millions de dollars et prolonge sa tr\u00e9sorerie jusqu'au quatri\u00e8me trimestre 2027.","inLanguage":"en-GB","isPartOf":{"@id":"https:\/\/geneveinfos.ch\/en\/#website"},"breadcrumb":{"@id":"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/#breadcrumblist"},"author":{"@id":"https:\/\/geneveinfos.ch\/en\/author\/redaction-geneve-infos\/#author"},"creator":{"@id":"https:\/\/geneveinfos.ch\/en\/author\/redaction-geneve-infos\/#author"},"datePublished":"2026-08-31T12:00:00+02:00","dateModified":"2026-11-09T13:37:08+01:00"},{"@type":"WebSite","@id":"https:\/\/geneveinfos.ch\/en\/#website","url":"https:\/\/geneveinfos.ch\/en\/","name":"Gen\u00e8ve Infos","description":"Le site d'informations de la r\u00e9gion genevoise","inLanguage":"en-GB","publisher":{"@id":"https:\/\/geneveinfos.ch\/en\/#organization"}}]},"og:locale":"en_GB","og:site_name":"Gen\u00e8ve Infos - Le site d'informations de la r\u00e9gion genevoise","og:type":"article","og:title":"Addex Therapeutics : tr\u00e9sorerie prolong\u00e9e jusqu\u2019\u00e0 fin 2027 - Gen\u00e8ve Infos","og:description":"Addex Therapeutics, biotech genevoise, l\u00e8ve 2,8 millions de dollars et prolonge sa tr\u00e9sorerie jusqu'au quatri\u00e8me trimestre 2027.","og:url":"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/","og:image":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg","og:image:secure_url":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg","og:image:width":1200,"og:image:height":630,"article:published_time":"2026-08-31T10:00:00+00:00","article:modified_time":"2026-11-09T12:37:08+00:00","article:publisher":"https:\/\/www.facebook.com\/profile.php?id=61576016541234","twitter:card":"summary_large_image","twitter:title":"Addex Therapeutics : tr\u00e9sorerie prolong\u00e9e jusqu\u2019\u00e0 fin 2027 - Gen\u00e8ve Infos","twitter:description":"Addex Therapeutics, biotech genevoise, l\u00e8ve 2,8 millions de dollars et prolonge sa tr\u00e9sorerie jusqu'au quatri\u00e8me trimestre 2027.","twitter:image":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg"},"aioseo_meta_data":{"post_id":"288857","title":null,"description":"Addex Therapeutics, a Geneva biotech, raises 2.8 million dollars and extends its cash runway into the fourth quarter of 2027.","keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2026-10-24 13:12:39","updated":"2026-11-09 13:24:30","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/geneveinfos.ch\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/\" title=\"Pharma &amp; biotech\">Pharma &amp; biotech<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tAddex Therapeutics : tr\u00e9sorerie prolong\u00e9e jusqu\u2019\u00e0 fin 2027\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/geneveinfos.ch\/en\/"},{"label":"Pharma &amp; biotech","link":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/"},{"label":"Addex Therapeutics : tr\u00e9sorerie prolong\u00e9e jusqu&rsquo;\u00e0 fin 2027","link":"https:\/\/geneveinfos.ch\/en\/2026\/08\/31\/addex-therapeutics-extends-its-cash-runway-into-the-fourth-quarter-of-2027\/"}],"_links":{"self":[{"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/posts\/288857","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/comments?post=288857"}],"version-history":[{"count":1,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/posts\/288857\/revisions"}],"predecessor-version":[{"id":322678,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/posts\/288857\/revisions\/322678"}],"wp:attachment":[{"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/media?parent=288857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/categories?post=288857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/tags?post=288857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}